Ryan Simon

Ryan brings deep legal experience in the life sciences sector, with expertise spanning research tools, medical devices and diagnostics, healthcare AI/tech, biotech and pharma. His practice at Inceptiv focuses on commercial transactions, outside general counsel, licensing, M&A, and healthcare regulatory & compliance. Ryan uniquely complements his legal background with a track record of driving growth and innovation through hands-on industry operational leadership in business development and investor relations. Ryan has worked across the full company lifecycle, from privately held startups to a large-cap public S&P 500 organization, including as VP of Investor Relations and Senior Corporate Counsel at Hologic, Inc. (formerly NASDAQ: HOLX), and as General Counsel of eBioscience from early-stage through its acquisition by Affymetrix (formerly NASDAQ: AFFX, acquired by NASDAQ: TMO).

Practice Areas

• Outside General Counsel
• Commercial Contracts and Transactions
• Technology and IP Licensing
• Healthcare Regulatory and Compliance
• Mergers & Acquisitions, Business Development
• Investor Relations and Corporate Communications Advisory

Prior Associations and Activities

• Hologic, Inc. (Cross-Functional Leader: Legal, BD & Investor Relations)
• Affymetrix, Inc. (Division General Counsel)
• eBioscience, Inc. (General Counsel, Business Development)

Education

• Gonzaga University School of Law – J.D.
• University of San Diego – M.B.A.
• University of California, Davis – B.S., Biotechnology

Bar Admissions

• California
• United States Patent & Trademark Office

Other Credentials

• California Real Estate Broker License